verapamil has been researched along with Cognition Disorders in 7 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three children with familial hemiplegic migraine presented with right-sided weakness, speech difficulty, altered mental status, and gait abnormalities." | 1.38 | Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children. ( Asghar, SJ; Glasier, C; Kaushik, C; Milesi-Hallé, A; Sharp, GB, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ponne, S | 1 |
| Kumar, CR | 1 |
| Boopathy, R | 1 |
| Kumar, A | 1 |
| Mishra, J | 1 |
| Chopra, K | 1 |
| Dhull, DK | 1 |
| Moore, CS | 1 |
| Miller, IN | 1 |
| Andersen, RL | 1 |
| Arndt, S | 1 |
| Haynes, WG | 1 |
| Moser, DJ | 1 |
| Asghar, SJ | 1 |
| Milesi-Hallé, A | 1 |
| Kaushik, C | 1 |
| Glasier, C | 1 |
| Sharp, GB | 1 |
| Popović, M | 1 |
| Caballero-Bleda, M | 1 |
| Popović, N | 1 |
| Bokonjić, D | 1 |
| Dobrić, S | 1 |
| Fogelman, J | 2 |
7 other studies available for verapamil and Cognition Disorders
| Article | Year |
|---|---|
Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Avoidance Learning; Brain; Cell Line, Tumor; Cell | 2020 |
Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Berberine; Cognition Disorders; Ma | 2016 |
Gender differences in neuropsychological performance in individuals with atherosclerosis: impact of vascular function.
Topics: Acetylcholine; Aged; Aged, 80 and over; Atherosclerosis; Blood Pressure; Blood Vessels; Cognition Di | 2011 |
Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children.
Topics: Adolescent; Anti-Inflammatory Agents; Brain Edema; Calcium Channel Blockers; Calcium Channels; Child | 2012 |
Neuroprotective effect of chronic verapamil treatment on cognitive and noncognitive deficits in an experimental Alzheimer's disease in rats.
Topics: Aggression; Alzheimer Disease; Animals; Avoidance Learning; Calcium Channel Blockers; Cognition Diso | 1997 |
Verapamil caused depression, confusion, and impotence.
Topics: Cognition Disorders; Confusion; Depressive Disorder; Erectile Dysfunction; Female; Humans; Hypertens | 1988 |
Verapamil may cause depression, confusion, and impotence.
Topics: Cognition Disorders; Confusion; Depression; Erectile Dysfunction; Humans; Male; Middle Aged; Verapam | 1987 |